191 related articles for article (PubMed ID: 24711484)
1. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
2. Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Li H; Kantoff PW; Giovannucci E; Leitzmann MF; Gaziano JM; Stampfer MJ; Ma J
Cancer Res; 2005 Mar; 65(6):2498-504. PubMed ID: 15781667
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Bauer SR; Richman EL; Sosa E; Weinberg V; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2013 Dec; 73(16):1786-95. PubMed ID: 24038157
[TBL] [Abstract][Full Text] [Related]
4. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
Abe M; Xie W; Regan MM; King IB; Stampfer MJ; Kantoff PW; Oh WK; Chan JM
BJU Int; 2011 Jan; 107(1):126-34. PubMed ID: 20477822
[TBL] [Abstract][Full Text] [Related]
5. Variation of the genes encoding antioxidant enzymes SOD2 (rs4880), GPX1 (rs1050450), and CAT (rs1001179) and susceptibility to male infertility: a genetic association study and in silico analysis.
Fallah F; Colagar AH; Saleh HA; Ranjbar M
Environ Sci Pollut Res Int; 2023 Aug; 30(36):86412-86424. PubMed ID: 37405601
[TBL] [Abstract][Full Text] [Related]
6. Associations between SNPs within antioxidant genes and the risk of prostate cancer in the Siberian region of Russia.
Oskina NA; Еrmolenko NA; Boyarskih UA; Lazarev A; Petrova VD; Ganov DI; Tonacheva OG; Lifschitz GI; Filipenko ML
Pathol Oncol Res; 2014 Jul; 20(3):635-40. PubMed ID: 24610081
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness.
Nikic P; Dragicevic D; Jerotic D; Savic S; Djukic T; Stankovic B; Kovacevic L; Simic T; Matic M
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676755
[TBL] [Abstract][Full Text] [Related]
8. Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
Woodson K; Tangrea JA; Lehman TA; Modali R; Taylor KM; Snyder K; Taylor PR; Virtamo J; Albanes D
Cancer Causes Control; 2003 Aug; 14(6):513-8. PubMed ID: 12948282
[TBL] [Abstract][Full Text] [Related]
9. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.
Margalit DN; Jordahl KM; Werner L; Wang X; Gwo-Shu Lee M; Penney KL; Batista JL; Martin NE; Chan JM; Kantoff PW; Stampfer MJ; Nguyen PL; Mucci LA
Clin Genitourin Cancer; 2015 Aug; 13(4):370-377.e1. PubMed ID: 25662905
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract.
Zhang Y; Zhang L; Sun D; Li Z; Wang L; Liu P
Mol Vis; 2011; 17():2325-32. PubMed ID: 21921984
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk.
Méplan C; Dragsted LO; Ravn-Haren G; Tjønneland A; Vogel U; Hesketh J
PLoS One; 2013; 8(9):e73316. PubMed ID: 24039907
[TBL] [Abstract][Full Text] [Related]
12. Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus.
Banerjee M; Vats P; Kushwah AS; Srivastava N
Br J Biomed Sci; 2019 Oct; 76(4):166-171. PubMed ID: 30900957
[No Abstract] [Full Text] [Related]
13. Genetic polymorphisms (Pro197Leu of Gpx1, +35A/C of SOD1, -262C/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus.
Kasznicki J; Sliwinska A; Kosmalski M; Merecz A; Majsterek I; Drzewoski J
Adv Med Sci; 2016 Mar; 61(1):123-9. PubMed ID: 26674569
[TBL] [Abstract][Full Text] [Related]
14. Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.
Chao CT; Chen YC; Chiang CK; Huang JW; Fang CC; Chang CC; Yen CJ
Oxid Med Cell Longev; 2016; 2016():8516748. PubMed ID: 26881045
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations of three important antioxidative enzymes SOD2, CAT, and GPX1 in nonalcoholic steatohepatitis.
Huang YS; Chang TE; Perng CL; Huang YH
J Chin Med Assoc; 2021 Jan; 84(1):14-18. PubMed ID: 33009206
[TBL] [Abstract][Full Text] [Related]
16. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
17. Effect of 593C>T GPx1 SNP alone and in synergy with 47C>T SOD2 SNP on the outcome of critically ill patients.
Majolo F; Oliveira Paludo FJ; Ponzoni A; Graebin P; Dias FS; Alho CS
Cytokine; 2015 Feb; 71(2):312-7. PubMed ID: 25497738
[TBL] [Abstract][Full Text] [Related]
18. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
Nordström T; Van Blarigan EL; Ngo V; Roy R; Weinberg V; Song X; Simko J; Carroll PR; Chan JM; Paris PL
Prostate; 2016 Mar; 76(4):339-48. PubMed ID: 26585352
[TBL] [Abstract][Full Text] [Related]
19. Association between GPX1 and SOD2 genetic polymorphisms and overall survival in patients with metastatic urothelial bladder cancer: a single-center study in Serbia.
Nikic P; Dragicevic D; Savic-Radojevic A; Pljesa-Ercegovac M; Coric V; Jovanovic D; Bumbasirevic U; Pekmezovic T; Simic T; Dzamic Z; Matic M
J BUON; 2018; 23(4):1130-1135. PubMed ID: 30358222
[TBL] [Abstract][Full Text] [Related]
20. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis.
Nahon P; Sutton A; Rufat P; Charnaux N; Mansouri A; Moreau R; Ganne-Carrié N; Grando-Lemaire V; N'Kontchou G; Trinchet JC; Pessayre D; Beaugrand M
J Hepatol; 2012 Feb; 56(2):426-32. PubMed ID: 21907168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
